SCHEMBL1509717

SCHEMBL1509717

O=C(O)[N]C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7903749 0.74
Bicarbonate SCHEMBL11228659 0.68
SCHEMBL5468 0.67
SCHEMBL27361 0.67
SCHEMBL5469 0.67
SCHEMBL7649949 0.67
SCHEMBL4056192 0.67
Ammonia Solution, Strong SCHEMBL21569238 0.63 CA1 (0.36)
Ammonia Solution, Strong SCHEMBL2353938 0.63 CA1 (0.36)
SCHEMBL2159919 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4957645-A REACTION PRODUCT OF POLYTHIOEPOXIDE AND LONG CHAIN HYDROCARBYL AMIDE OR IMIDE EXXON CHEMICAL PATENTS INC. (US) 1990-09-18 US claimed
CN-107438607-A BICYCLIC HETEROCYCLES AS FGFR INHIBITORS 因赛特公司 2017-12-05 CN disclosed
EP-1512397-B1 O-SUBSTITUTED HYDROXYARYL DERIVATIVES INST MED MOLECULAR DESIGN INC (JP) 2014-10-08 EP disclosed
EP-2298790-A1 Daptomycin analogs as antibacterial agents Cubist Pharmaceuticals, Inc. (US) 2011-03-23 EP disclosed
US-20100113770-A1 O-SUBSTITUTED HYDROXYARYL DERIVATIVES INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2010-05-06 US disclosed
US-7700655-B2 Antiallergic agents INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2010-04-20 US disclosed
US-7626042-B2 O-substituted hydroxyaryl derivatives INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2009-12-01 US disclosed
US-20080311074-A1 Inhibitors against activation of NF-kappaB INSTITUTE OF MEDICAL MOLECULAR DESIGN INC. (JP) 2008-12-18 US disclosed
US-20080234233-A1 MEDICAMENT FOR TREATMENT OF NEURODEGENERATIVE DISEASES INSTITUTE OF MEDICINAL MOLECULAR DESIGN INC. (JP) 2008-09-25 US disclosed
US-20080090779-A1 ANTIALLERGIC AGENTS INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2008-04-17 US disclosed
EP-0705279-B1 TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES SELECTIDE CORP (US) 2003-02-19 EP disclosed
US-6090912-A MULTIPLICITY OF SEPARATE SOLID SUPPORTS WITH SURFACE HAVING SUCEPTIBLE LINKER TO SINGLE SPECIES OF TEST COMPOUND AND WITH INTERIOR HAVING ATTACHED NON-CLEAVABLE CODING MOLECULE; FOR SCREENING LIGANDS OR ACCEPTORS SELECTIDE CORPORATION (US) 2000-07-18 US disclosed
EP-0705279-A4 TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES SELECTIDE CORP (US) 1999-03-24 EP disclosed
US-5840485-A SYNTHETIC TEST COMPOUNDS ATTACHED TO SEPARATE PHASE SYNTHESIS SUPPORTS THAT ALSO CONTAIN CODING MOLECULES THAT ENCODE THE STRUCTURE OF THE SYNTHETIC TEST COMPOUND SELECTIDE CORPORATION (US) 1998-11-24 US disclosed
EP-0705279-A1 TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES SELECTIDE CORPORATION (US) 1996-04-10 EP disclosed
EP-0425369-B1 Composition for cleaning products, its preparation process and cleaning product containing it ROQUETTE FRERES (FR) 1995-11-22 EP disclosed
WO-1994028028-A1 TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES SELECTIDE CORPORATION (US) 1994-12-08 WO disclosed
US-4962225-A ADAMANTYL ESTERS FOR PEPTIDE SYNTHESIS Watanabe, Hidehiko (JP) 1990-10-09 US disclosed
US-4713450-A 2-thiacephems and (5R) penems derivatives FARMITALIA CARLO ERBA S.P.A. (IT) 1987-12-15 US disclosed
US-4585874-A Process for preparing penem derivatives FARMITALIA CARLO ERBA S.P.A. (IT) 1986-04-29 US disclosed